Glend Llandtada - Philippines

“This circular shall not cover grocery stores, supermarkets, convenience stores, chandler, kiosks and other similar stores.”

Glend Llantada
General Manager
Asia Actual Philippines

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sources and Links

The Philippines FDA Issues Guidance for Retailers of Medical Devices

Published on: October 15th, 2021

Direct to Consumer Retailers will Have Additional Requirements

On October 7, 2021, the Philippines FDA released FDA Circular No.2021-0021 | Guidelines on the Licensing of Retailers of Medical Devices in the Philippines. The new regulations apply to establishments that provide medical devices Direct to Consumers (DTC) including pharmacies and eCommerce storefronts. These establishments will now need to apply for a License to Operate (LTO) and staff a qualified person in accordance with AO No. 2020-0017. Establishments already registered with the FDA will need to amend their LTO to include the activity of a “retailer.” The FDA-issued LTO will then need to be displayed inside the establishment.

Entities Affected by the New Requirements

Establishment such as retail stores, clinics (except “those covered by the one stop shop licensing system”), sellers of online shopping website, social media platforms and/or tv shopping companies, operator of medical device vending machines, optical shops, drug outlets, such as drugstores, or boticas, and retail outlets for non-prescription drugs (RONPD). This circular shall not cover grocery stores, supermarkets, convenience stores, chandler, kiosks and other similar stores (AO 2020-0017).

Fees at the time of publishing are as follows:

Activity Amount Remarks
Initial ₱2,000.00 Valid for 2 years
Renewal ₱3,000.00 Valid for 3 years
Variation ₱500.00

Do’s and Don’ts

The guidance reiterates that retailers are only allowed to sell registered medical devices intended for home use and with a Certificate of Medical Device Notification (CMDN) or Certificate of Medical Device Registration (CMDR). Retailers of prescription devices, such as pharmacies, must only sell to customers with valid prescriptions issued by an authorized professional. Retailers of ophthalmic lenses, prisms, contact lenses and their accessories and solutions, low vision aids, etc. governed by RA 8050 or the “Revised Optometry Law of 1995,” will need to have an optometrist as their Qualified Person. The Qualified Person will be responsible for handling Adverse Events, ensure that medical devices are issued with authorizations from FDA, ensure compliance of establishment, etc.

Online selling of prescription medical devices is prohibited. Retailers of these devices can advertisement online but are not allowed to let the consumer purchase directly. All retailers must immediately stop the sell of unlicensed medical devices that have been banned or declared unregistered or counterfeit by the FDA. Establishments found in violation of these regulations will be sanctioned in accordance with the Republic Act No. 9711.

Spot Checks

The FDA will from time to time conduct spot checks on establishments falling under these requirements and will expect to see the following upon arrival:

  1. Proof of Business Name registration
  2. Business Permit (if establishment address is different from business name registration address)
  3. Credentials of qualified person:
    1. Valid PRC ID/ Diploma for those without Board Exam
    2. Certificate of attendance to seminars on medical devices given by the academe/ industry
  4. SOP
  5. Relevant reference materials (Issuances related to medical devices)
  6. Valid LTO
  7. Copies of CMDN or CMDR
  8. Risk Management Plan

Grace Period

All existing retailers prior to the issuance of this Circular shall be given a period of two (2) years from the effectivity of this Circular to comply with the provisions thereof.

Come Grow With Us

Asia Actual specializes in helping medical device manufacturers grow their sales in Asia and with experienced, bi-lingual commercial and regulatory experts on the ground in each market. Contact Asia Actual today with any questions or support requests for the Philippines.

Blog Posts

CDSCO Issues Updates to IVD Classification List in India

The Central Drugs Standard Control Organisation (CDSCO) of India issued a notice (PDF) on October 25, 2023 classifying in-vitro diagnostic (IVD) medical devices under medical device rules. The updates to IVD classification in India include intended use, associated risk, and other parameters.

Embracing Innovation and Collaboration: Highlights from the 15th CII Global MedTech Summit

On October 6, 2023, a team of enthusiastic members from the AAI (Artificial Intelligence and Innovation) group, including Ashoniya Puri, Sanjay Singh, and Rajat Budhori, had the honor of attending the prestigious 15th CII Global MedTech Summit. Hosted by the Confederation of Indian Industry (CII), one of India's largest industry bodies, this event brought together key players in the MedTech sector, both from India and abroad. The summit revolved around the central theme, "Paving the way for a USD 50 billion MedTech Industry by 2030," signifying a collective vision for the industry's future growth.


On September 18, 2023, The Directorate General of Drug Administration (DGDA) published the Drug and Cosmetics Act 2023 formalizing the regulatory requirements of medical and diagnostic devices in Bangladesh with immediate effect.  A translated version of the document is available on Asia Actual’s website here.  All medical devices now require a Marketing Authorization Certificate to clear Customs and be sold on the market in Bangladesh.